483
Aurobindo Pharma LimitedAurobindo Pharma Limited – FDA 483, Feb 21, 2020
Record Details
An FDA inspection of Aurobindo Pharma Ltd in Bachupally, Telangana, revealed significant deficiencies in manufacturing practices for drug products. Observations included inadequate facilities for contamination prevention, failures in microbiological contamination control for sterile products, and insufficient employee training. The firm also demonstrated poor handling of discrepancies, out-of-specification results, and customer complaints, alongside unvalidated test methods.
View Company Profile
ID · 892c968e-c743-4108-bf0a-b6616316dc36
Other documents for Aurobindo Pharma Limited
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.